October 17, 2022
Video
Glenn J. Hanna, MD, discusses the results of a study investigating nivolumab as treatment for proliferative leukoplakia leading to oral cancer.
October 12, 2022
Video
Glenn J. Hanna, MD, discusses proliferative leukoplakia and risk of oral cancer.
July 06, 2016
Article
Squamous cell carcinoma of the head and neck (SCCHN) is an immunosuppressive disease, as its patients often demonstrate immune dysregulation that correlates with poorer outcomes. Trials are underway combining chemoradiotherapy with immune checkpoint inhibitors.